This site is intended only for the use of UK Healthcare Professionals

ModuLife Patient Story - Lee from Cork, Ireland

Gastro Intestinal
Gastro Intestinal
  • 31/08/2022
Nestlé Health Science Banner

Video description

Lee and his parents share their experience with the ModuLife Program and the Crohn's Disease Exclusion Diet (CDED).

Other content you might be interested in
Challenges of Managing Adolescents on Modulen® IBD

Crohn’s disease (CD) is a chronic inflammatory bowel disease characterised by patchy, transmural inflammation and ulceration affecting anywhere in the gastrointestinal tract with ileocolonic disease being the most frequent presentation.1 While the exact cause of CD is not known, it is thought to result from a complex interplay between intestinal bacteria and environmenta...

Modulen® IBD - Reaching New Heights with Clinical Evidence

This following shows a non-extensive list of the key clinical evidence behind Modulen® IBD. You will find a chronological summary of all the data collected and published over recent years that demonstrate the safety and efficacy of this product in Crohn’s Disease. Modulen® IBD is the only enteral product with extensive clinical evidence in Crohn’s Disease. All these studies have great...

The use of Modulen® IBD as exclusive enteral nutrition in adult crohn’s disease

Crohn’s disease (CD) is a chronic inflammatory bowel disease characterised by patchy, transmural inflammation and ulceration affecting anywhere in the gastrointestinal tract with ileocolonic disease being the most frequent presentation.1 While the exact cause of CD is not known, it is thought to result from a complex interplay between intestinal bacteria and environmenta...

ModuLife & Crohn's Disease Exclusion Diet Training Day

What do leading IBD experts say about the Crohn's Disease Exclusion Diet (CDED)? Learn more from the experts behind the diet and the clinical trials in the video from the first "CDED Expert" training day that took place in Copenhagen, March 2019.